Hyperkalemia resident survival guide: Difference between revisions
Jump to navigation
Jump to search
Mahmoud Sakr (talk | contribs) No edit summary |
Rim Halaby (talk | contribs) |
||
| Line 24: | Line 24: | ||
===Common Causes=== | ===Common Causes=== | ||
*[[Adrenal insufficiency]] | |||
*[[Diabetic ketoacidosis]] | |||
*[[Iatrogenic]] | |||
*[[Medications]]: [[ACE inhibitor|ACE inhibitors]], [[angiotensin II receptor antagonist|angiotensin receptor blockers]], [[amiloride]], [[spironolactone]], [[NSAIDS]], [[ciclosporin]], [[tacrolimus]], [[trimethoprim]], [[pentamidine]], [[succinylcholine]] | |||
*[[Pseudohyperkalemia]] | *[[Pseudohyperkalemia]] | ||
*[[Renal insufficiency]] | *[[Renal insufficiency]] | ||
*[[RTA#Type 4 RTA (Hypoaldosteronism)|Renal tubular acidosis type 4]] | *[[RTA#Type 4 RTA (Hypoaldosteronism)|Renal tubular acidosis type 4]] | ||
== Management== | == Management== | ||
Revision as of 15:44, 26 July 2013
|
Hyperkalemia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hyperkalemia resident survival guide On the Web |
|
American Roentgen Ray Society Images of Hyperkalemia resident survival guide |
|
Risk calculators and risk factors for Hyperkalemia resident survival guide |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Mahmoud Sakr, M.D. [2]
For hyperkalemia smart algorithm click here
Definition
Hyperkalemia is defined as a serum potassium concentration greater than 5.5 mEq/L in adults. Levels higher than 7 mEq/L can lead to significant hemodynamic compromise.
Causes
Life Threatening Causes
Life-threatening causes include conditions which result in death or permanent disability within 24 hours if left untreated.
- Acute renal failure
- Adrenal insufficiency
- Diabetic ketoacidosis
- Large IV doses of calcium chloride or calcium gluconate
- Massive hemolysis
- Metabolic acidosis
- Rapid tissue necrosis
- Rhabdomyolysis
- Tumor lysis syndrome
Common Causes
- Adrenal insufficiency
- Diabetic ketoacidosis
- Iatrogenic
- Medications: ACE inhibitors, angiotensin receptor blockers, amiloride, spironolactone, NSAIDS, ciclosporin, tacrolimus, trimethoprim, pentamidine, succinylcholine
- Pseudohyperkalemia
- Renal insufficiency
- Renal tubular acidosis type 4
Management
Shown below is an algorithm summarizing the approach to hyperkalemia.
| High potassium level | |||||||||||||||||||||||||||||||||||||||||||||||||||
| R/O Pseudohyperkalemia Repeat potassium level | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Check vital signs Stabilize the patient Order an EKG Concise history and physical exam | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Assess EKG | |||||||||||||||||||||||||||||||||||||||||||||||||||
EKG changes, e.g. loss of P waves, hyperacute T waves and widened QRS | No changes in EKG, stable patient | ||||||||||||||||||||||||||||||||||||||||||||||||||
| Use rapidly acting transient agents, e.g Insulin, Dextrose, IV Calcium; with Ca gluconate generally preferred over Ca chloride, inhaled Beta2 agonists | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Kayexalate, orally, and also can be given rectally in unconscious patients to avoid risks of aspiration | IV hydration | Stop potential causative medications | |||||||||||||||||||||||||||||||||||||||||||||||||
| Use carefully in potential heart failure patients, consider diuresis when clinically appropriate | Consult with nephrology for resistant and severe cases of hyperkalemia may require urgent dialysis, yet rare | ||||||||||||||||||||||||||||||||||||||||||||||||||
Do's
- Place the patient on a closely monitored bed for potential fatal arrhythmias, esp. with levels higher than 6.5.
- Repeat basic metabolic panels frequently.
- Stop the offending medications that are associated with hyperkalemia.
- Keep the patient well hydrated.
- Check levels of other electrolytes such as Magnesium and phosphorus as it may be abnormal as well.
- Consider consultation with nephrology.
Dont's
- Don't over use kayexalate, as it has been reported to cause colonic transmural necrosis.[1]
- Don't over treat with IV bicarbonate as it can lead to rebound metabolic alkalosis.
References
- ↑ Lillemoe KD, Romolo JL, Hamilton SR, Pennington LR, Burdick JF, Williams GM (1987). "Intestinal necrosis due to sodium polystyrene (Kayexalate) in sorbitol enemas: clinical and experimental support for the hypothesis". Surgery. 101 (3): 267–72. PMID 3824154.